ProMIS Neurosciences Inc. is trading 7.2% up at $9.79 today, rebounding from a 6.2% decline in the previous session as it continues to fluctuate within a highly volatile range.
- The move appears to be driven by idiosyncratic trading in a thin, speculative biotech name rather than a reaction to new fundamentals or news.
- There have been no fresh company-specific announcements, regulatory filings, or major analyst actions reported so far today.
- The upward price action occurs despite a lack of identifiable catalysts, though it coincides with a generally positive broader market backdrop.